جست‌وجوی استاد و پژوهشگر

• Environmental Health Engineering
• Wastewater-Based Epidemiology
• Bioremediation
• +۷ مورد دیگر

Rolf Halden is a Professor and Center Director at Arizona State University, holding appointments in the School of Sustainable Engineering and the Built Environment, the Biodesign Center for Environmental Health Engineering, and the Global Futures Scientists and Scholars program. He is a leading expert in environmental health engineering, wastewater-based epidemiology, and bioremediation. Education: Ph.D. in Civil (Environmental) Engineering, University of Minnesota (1997) M.S. in Civil (Environmental) Engineering, University of Minnesota (1994) M.S. in Biology, Technical University of Braunschweig, Germany (1992) Postdoctoral Fellow, Environmental Science, Lawrence Livermore National Laboratory (1998) Research Focus: Halden’s research integrates environmental chemistry, public health, and sustainability to understand how anthropogenic chemicals affect ecological and human health. His lab uses advanced mass spectrometry (LC-MS/MS, MALDI-TOF) to track pollutants such as PPCPs, microplastics, pesticides, and dioxins across air, water, soil, and biological systems. He pioneered the use of wastewater treatment plants as public health observatories, enabling real-time tracking of disease, drug use, and environmental exposures. Scientific Awards & Recognition: Leadership Award, Arizona State University (2018) Rocky Mountain Emmy Award (2018) Leroy E. Burney Lecturer, Johns Hopkins School of Public Health (2011) ACS Expert Program Member (2014–present) NIEHS Superfund R01 Working Group National Leader (2012–2014) Labs & Teams: Halden is the Founding Director of the Biodesign Center for Environmental Health Engineering at ASU, where he leads a multidisciplinary team focused on environmental proteomics, bioremediation, and diagnostic tool development. He also co-leads the Human Health Observatory , a national wastewater monitoring network. Grants & Funding: Halden has secured major funding from NSF, NIH, EPA, DoD, and private industry. Notable projects include the development of in-situ groundwater monitoring devices, national wastewater surveillance of SARS-CoV-2, and studies on microplastics and neurodegenerative disease.

Syed Hani Hassan Abidiمشاهده پروفایل

دانشیار

• Virology
• Immunology
• Viral Oncology
• +۷ مورد دیگر

Syed Hani Hassan Abidi is an Associate Professor at the Department of Biomedical Sciences , School of Medicine , Nazarbayev University , Kazakhstan. His research integrates virology , immunology , viral oncology , and bioinformatics , with a focus on HIV molecular epidemiology , viral evolution , and drug resistance . He has led international projects across Pakistan, Kenya, Afghanistan, and Kazakhstan, and is recognized for innovative teaching and MOOC development. Education: PhD in Virology and Immunology Research Interests: His laboratory employs bioinformatics (machine learning, AI), genomics , and proteomics to study HIV phylodynamics , viral co-infections , and oncogenic viruses like EBV in prostate cancer. He also explores microbiome-immunity interactions and designs antiviral drugs/vaccines . Recent Research Trends: His 2025 publications emphasize COVID-19 immunopathology , HIV/syphilis epidemiology in Pakistan , and particle physics contributions via ATLAS , showcasing interdisciplinary impact. Awards & Recognition: Outstanding Teachers Award (2019, Aga Khan University) Fellowship of Higher Education (UK, 2022) Teaching & Grants: He pioneered Pakistan’s first MOOC on Computer-Based Drug Discovery (2014) and received a 2022 SoTL grant for MOOC-based molecular biology education. His teaching integrates animations , films , and flipped classrooms . Collaborations & Labs: Leads projects on HIV drug resistance , HCV genomics in Kazakhstan , and AI-driven dementia diagnostics (Kazakh Brain Atlas). His lab collaborates with global institutions to advance viral disease surveillance and therapeutic innovation .

Pieter Abbeelمشاهده پروفایل

استاد

• Artificial Intelligence (AI)
• Robotics
• Machine Learning
• +۵ مورد دیگر

Pieter Abbeel is a Professor in the Department of Electrical Engineering and Computer Sciences (EECS) at the University of California, Berkeley. He leads the Berkeley Robot Learning Lab and co-directs the Berkeley Artificial Intelligence Research (BAIR) Lab. His work focuses on advancing AI and robotics through deep reinforcement learning, imitation learning, and unsupervised learning, with applications in automation, healthcare, and education. Abbeel's research also explores the societal implications of AI and its potential to revolutionize other scientific and engineering fields. Education: Ph.D. in Computer Science, Stanford University (2008) M.S. in Electrical Engineering, KU Leuven, Belgium (2000) Research Interests: Robotics, AI, Machine Learning, Reinforcement Learning, Autonomous Systems, and Applications in Surgery, Manufacturing, and Education. Recent Article Trends: Focus on multimodal learning, robot manipulation, protein structure prediction, and scalable AI systems. Key areas include sim-to-real transfer, embodied AI, and foundation models for decision-making. Awards & Honors: IEEE Kiyo Tomiyasu Award (2022) ACM Prize in Computing (2021) IEEE Fellow (2018) MIT Tech Review TR35 (2011) Advising & Grants: Advises startups and has received grants from NSF, DARPA, and industry partnerships. Notable students include those advancing robotics, reinforcement learning, and bioAI. Labs & Initiatives: Berkeley Robot Learning Lab, BAIR Lab, and collaborations with the Center for Human-Compatible AI (CHAI). Founded companies include Gradescope, Covariant, and Berkeley Open Arms.

• Lymphoma
• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma
• +۵ مورد دیگر

Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.

• Quantum-safe cryptography
• Lattice-Based Cryptography
• Post-Quantum Cryptography
• +۴ مورد دیگر

Ron Steinfeld is an Associate Professor in the Department of Software Systems & Cybersecurity at Monash University, Australia. He holds editorial roles in Designs Codes and Cryptography (since 2017) and has served on technical committees for top-tier conferences like ASIACRYPT, CRYPTO, and EUROCRYPT. His research focuses on quantum-safe cryptography, lattice-based cryptography, and blockchain security, with over 80 refereed publications and AUD$4M+ in research funding. Education: BSc Mathematics and Physics (Monash University, 1998) BE (Hons., First Class) Electrical and Computer Systems (Monash University, 2000) PhD Computer Science (Monash University, 2003) Research Interests: Design and analysis of cryptographic algorithms, quantum-safe protocols, lattice-based security foundations, and blockchain applications. His work underpins NIST standard algorithms like Kyber and Dilithium through structured lattice problem research. Recent Articles Trends: Focus on privacy-preserving blockchain protocols, post-quantum signature schemes, encrypted data search, and cryptographic applications in adversarial AI. Recent work includes fair Bitcoin watchtower schemes and genomic database privacy solutions. Awards: ASIACRYPT 2015 Best Paper Award Advising & Grants: Supervises PhD projects on quantum-safe cryptography and blockchain security. Leads initiatives like the AUD$4M ARC-funded Quantum Information Technology project. Collaborates with industry partners including CSIRO/Data61. Labs/Teams: Key contributor to Monash’s cybersecurity and cryptography research groups, involving interdisciplinary projects on materials discovery ( Æinstein initiative) and post-quantum blockchain security.

Anthony Rollettمشاهده پروفایل

استاد

• Additive Manufacturing
• Advanced Materials Processing and Manufacturing
• Digital Twins
• +۶ مورد دیگر

Anthony Rollett is a Professor in the Department of Materials Science and Engineering at Carnegie Mellon University , where he has been a faculty member since 1995. He serves as the Principal Investigator and Co-Director of the NASA-supported Institute for Model-Based Qualification & Certification of Additive Manufacturing (IMQCAM) and co-director of the Next Manufacturing Center . Prior to CMU, he held leadership roles at Los Alamos National Laboratory (1991-1995). Education: Ph.D., Materials Engineering, Drexel University (1987) MA, Metallurgy and Materials Science, Cambridge University (1977) Research Interests: Rollett’s work focuses on microstructural evolution and microstructure-property relationships in 3D using experiments and simulations. His expertise spans additive manufacturing , metal 3D printing , materials for energy systems , grain growth , recrystallization , and stereology , with techniques like high-energy diffraction microscopy (HEDM) and dynamic x-ray radiography (DXR) . Scientific Contributions: He has over 320 peer-reviewed publications and an h-index >80 . His recent articles highlight machine learning for laser processing , fatigue analysis of additively manufactured alloys, and design optimization for heat exchangers in supercritical CO2 and solar thermal applications . Scientific Awards: Fellow of ASM International (1996) Fellow of the Institute of Physics (UK) (2004) Fellow of The Minerals, Metals & Materials Society (TMS) (2011) Cyril Stanley Smith Award (TMS, 2014) Member of Honor, French Metallurgical Society (2015) US Steel Professor (2017) Francqui International Professor (2020-2021) International FAME Award (2023) Leadership & Impact: Rollett co-led the development of a NASA Space Technology Research Institute for additive manufacturing and established a new master’s program in additive manufacturing (2018). His research group is funded by industry , federal agencies , and Pennsylvania state grants . He also serves on the Basic Energy Science Advisory Committee and Defense Programs Advisory Committee for the Department of Energy.

Mihai Popمشاهده پروفایل

استاد

• Bioinformatics
• Genomics
• Computational Biology
• +۳ مورد دیگر

Dr. Mihai Pop is a Professor of Computer Science and Director of the University of Maryland Institute for Advanced Computer Studies (UMIACS). He holds appointments in the Department of Computer Science, UMIACS, and the Center for Bioinformatics and Computational Biology (CBCB). His research focuses on computational biology, metagenomics, and algorithm development for genomic data analysis. He received a Ph.D. in Computer Science from Johns Hopkins University (2000), followed by work at The Institute for Genomic Research (TIGR) developing genome assembly algorithms. Education: Ph.D., Computer Science, Johns Hopkins University, 2000. Research Interests: Bioinformatics, genomics, metagenomics, computational geometry, software testing. His lab develops tools for analyzing microbial communities and has pioneered methods for metagenomic assembly and analysis. Notable tools include the AMOS genome assembly toolkit. Recent Article Trends: Recent work emphasizes long-read sequencing, metagenomic profiling (e.g., TIPP3), and strain-level analysis (e.g., Strainy). He addresses challenges in scaling sequence-based searches and improving taxonomic resolution in large datasets. Awards: ACM Fellow (2019), ISCB Fellow (2022), UMD Excellence in Teaching Award (2015). Grants & Leadership: Co-leader of the Human Microbiome Project data analysis group. Active in diversity initiatives to promote inclusivity in computational fields. Labs/Teams: Pop Lab (pop-lab.org) focuses on computational methods for microbial genomics and metagenomics.

Marcus Smithمشاهده پروفایل

دانشیار

• Technology Law and Regulation
• Artificial Intelligence Ethics
• Genomic Data Governance
• +۴ مورد دیگر

Marcus Smith is an Associate Professor in Law at the Charles Sturt University , where he teaches LAW222 Technology Law and directs the Bachelor of Laws program. He holds advanced degrees from the Australian National University (PhD, LLM) and the University of Cambridge (MPhil). His research spans technology law and regulation , focusing on genomic data governance biometric identification AI ethics blockchain policy cybersecurity surveillance law He leads the Contemporary Threats to Australian Security research group and serves as Chief Investigator on an NHMRC-funded project (MRF2015531) addressing genomic dataset governance. His recent work analyzes algorithmic bias in facial recognition AI in healthcare blockchain's regulatory challenges post-pandemic cybercrime surveillance ethics data security frameworks He actively supervises PhD and honours students in technology law and contributes to law reform through submissions to international bodies like the UN Human Rights Council .

Katja Hoseمشاهده پروفایل

استاد

• Knowledge Graphs
• Semantic Web
• Data Management
• +۷ مورد دیگر

Katja Hose is a Full Professor of Data Management at TU Wien's DBAI research unit, heading the Data Management and Knowledge-Driven AI Lab. She previously held a Poul Due Jensen Foundation Professorship at Aalborg University. Her research focuses on data and knowledge engineering, including graph databases, knowledge graphs, querying, analytics, and machine learning, with interdisciplinary applications in bioscience, healthcare, and environmental assessment. Education: PhD in Computer Science (Ilmenau University of Technology, 2009), Postdoc at Max Planck Institute for Informatics (2009–2012). Academic roles include Program Co-Chair for ISWC 2024 and EDBT 2023, and editorial board membership at VLDBJ and TGDK. She leads projects like TARGET (health virtual twins) and ARMADA (data management). Research Interests: Knowledge Graphs, Semantic Web, Big Data, Machine Learning, Data Integration, and Provenance Systems. Key contributions include SHACL shape extraction, conversational data analytics, and environmental knowledge graphs. Awards include the 2025 Distinguished Meta-Reviewer Award and 2024 Manfred Paul Award. Advising and Grants: Supervised students including E. Pürmayr (Diploma Thesis 2025). Active in EU projects (TARGET, ARMADA) and grant coordination. Labs/Teams: DMKI Lab at TU Wien, collaborating with interdisciplinary teams in healthcare and environmental science.

John P.A. Ioannidisمشاهده پروفایل

استاد

• Meta-research
• Evidence-based Medicine
• Research Reproducibility
• +۱۲ مورد دیگر

John P.A. Ioannidis is the C.F. Rehnborg Professor in Disease Prevention and Professor of Medicine, Health Research and Policy, Biomedical Data Science, and Statistics at Stanford University. He is Co-Director of the Meta-Research Innovation Center at Stanford (METRICS) and an Einstein BIH Visiting Fellow at Charité - Universitätsmedizin Berlin. His academic appointments span multiple departments and institutes at Stanford, including the Stanford Prevention Research Center, Biomedical Data Science, and Statistics. He is internationally recognized for his work in meta-research, evidence-based medicine, and research reproducibility. Ioannidis holds an MD and DSc in Biopathology from the National University of Athens, with training in internal medicine and infectious diseases from Harvard and Tufts. He previously chaired the Department of Hygiene and Epidemiology at the University of Ioannina Medical School and held adjunct positions at Harvard, Tufts, and Imperial College. He joined Stanford in 2010, where he launched the PhD program in Epidemiology & Clinical Research, the MS in Community Health & Prevention Research, and METRICS in 2014. His research focuses on improving research methods, appraising biases, enhancing reproducibility, and integrating evidence across scientific disciplines. He is a pioneer in meta-research, with seminal contributions on the reliability of published findings, statistical practices, and research synthesis. His influential 2005 paper, "Why Most Published Research Findings Are False," is the most-accessed article in PLoS history. His recent work examines peer review, data sharing, AI in medicine, and pandemic research impact, consistently advocating for transparency and methodological rigor. His publications span epidemiology, statistics, genomics, clinical trials, and meta-analysis, with a strong emphasis on bias detection, replication, and open science. Trends in his recent articles highlight concerns about research integrity, citation practices, peer review reform, and the scientific response to global health crises. Founders' Medal for Lifetime Contributions to Meta-science (2024) Honorary doctorates from McMaster, Thessaloniki, Edinburgh, Tilburg, Athens, and Rotterdam Elected member, US National Academy of Medicine (2018) Elected member, European Academy of Sciences and Arts (2015) President, Association of American Physicians (2023–2024) President, Society for Research Synthesis Methodology Gordon Award, NIH (2019) Chanchlani Global Health Award (2017) Highly Cited Researcher (Clarivate) in Clinical Medicine, Social Sciences, and Psychiatry Ioannidis has advised numerous students and mentored early-career researchers. He has served as Senior Advisor for Knowledge Integration at the National Cancer Institute (2012–2016) and Editor-in-Chief of the European Journal of Clinical Investigation (2010–2019). He has received over 700 invited lectures and is deeply involved in shaping research policy and scientific infrastructure. He leads METRICS, a hub for meta-research innovation, and is affiliated with multiple Stanford institutes, including Bio-X, the Cardiovascular Institute, and the Stanford Cancer Institute.

• Microbiology
• Infectious Diseases
• Cell Biology
• +۷ مورد دیگر

Manuel R. Amieva is a Professor at Stanford University School of Medicine , holding joint appointments in Pediatrics - Infectious Diseases and Microbiology & Immunology . He is also a member of the Maternal & Child Health Research Institute (MCHRI) . His clinical practice at Stanford Medicine Children's Health focuses on pediatric infectious diseases. Education: Medical Education: Stanford University School of Medicine (1997) Fellowship: Stanford University Pediatric Infectious Disease Fellowship (2004) Internship & Residency: Stanford Health Care at Lucile Packard Children's Hospital (1998-1999) Dr. Amieva's research investigates host-pathogen interactions at epithelial barriers, with specific expertise in Helicobacter pylori , Listeria monocytogenes , Salmonella enterica , and Staphylococcus aureus . His lab develops innovative organoid culture systems with controlled polarity to study microbial colonization and oncogenic mechanisms. Key discoveries include: H. pylori's manipulation of epithelial junctions via the CagA protein Listeria's exploitation of cell extrusion sites for invasion Staphylococcus toxin interactions with adherens junctions Gastric stem cell activation by pathogens Recent publication trends show continued leadership in infectious disease mechanisms (2020-2025), with a focus on: Pathogen-specific epithelial breach strategies Organoid modeling of viral/bacterial interactions Redox-dependent host factor regulation Single-cell spatial transcriptomic analyses Multi-institutional educational frameworks His scientific collaborations span disciplines including: Gastric cancer genomics initiatives COVID-19 lung infection models Stem cell-microbe interactions Medical education reform projects Dr. Amieva maintains active clinical research while mentoring students in both the Microbiology & Immunology and Pediatrics programs. His lab at Stanford employs advanced 3D confocal microscopy and organ-on-a-chip technologies to visualize epithelial colonization dynamics.

• Bioinformatics
• Genomics
• Transcriptomics
• +۶ مورد دیگر

Owen R. White is a Professor in the Department of Epidemiology & Public Health at the University of Maryland School of Medicine, serving as Associate Director of the Institute for Genome Sciences and Associate Director of Research Collaboration & Development. He leads a team of 25 scientists and engineers developing genomic annotation pipelines and data analysis tools for state-of-the-art research in microbiome and multi-omic studies. His academic background includes: BS in Biotechnology from the University of Massachusetts (1985) PhD in Molecular Biology from New Mexico State University (1992) Postdoctoral Fellowship in Genome Informatics at the Institute for Genomic Research (TIGR) (1994) Dr. White's research spans bioinformatics, genomics, transcriptomics, and metagenomics with emphasis on data management, metadata standards, ontologies, and cloud systems. His work has been foundational for large-scale initiatives like the Human Microbiome Project (HMP) and Integrative Human Microbiome Project (iHMP), generating over 50,000 datasets totaling 10 terabytes of multi-omic data. Analysis of his recent publications reveals a strong trend toward neuroscience multi-omics (BRAIN Initiative), cloud-based data infrastructure, and ethical data sharing frameworks. His work consistently bridges microbiome research with emerging fields like single-cell analysis and Alzheimer's disease biomarker discovery through integrated data platforms. Notable awards include: Benjamin Franklin Award for Open Access in the Life Sciences (2015) Kumho Science International Award in Plant Molecular Biology and Biotechnology (2001) As Principal Investigator for major NIH-funded centers, he has secured sustained support for the HMP Data Analysis and Coordination Center and iHMP Data Coordination Center. His team's work combines fee-for-service models with collaborative research funding to maintain cutting-edge genomic analysis capabilities. The Institute for Genome Sciences houses his computational team responsible for developing production annotation pipelines, database systems, and visualization tools that serve researchers across the University of Maryland School of Medicine and national consortia.

• Food Safety
• Food Chain Integrity
• Microbiological Risk Assessment
• +۶ مورد دیگر

Professor Francis Butler is a Full Professor at University College Dublin's School of Biosystems and Food Engineering, where he has been since 1990. His academic roles include research leadership in food safety, food chain integrity, and microbial risk assessment. He leads the UCD Institute for Food and Health and the UCD Centre for Food Safety as a Principal Investigator. Education: BE, Grad Dip University Teaching & Learning, MBA, and PhD from University College Dublin. Research Focus: His work centers on food safety hazards, quantitative risk assessment, and next-generation sequencing for pathogen identification. Recent projects include Listeria monocytogenes growth modeling, norovirus in oysters, and hepatitis E in pork products. He has secured over €6 million in research grants, including EU-funded projects like FOODINTEGRITY and SIGMACHAIN. Awards & Recognition: European Food Safety Authority Fellowship, Marie Sklodowska-Curie Fellowship, and UCD Teaching Grant. He coordinates international educational programs, including the UCD MSC Food Safety and Risk Analysis. Professional Activities: Member of EFSA advisory committees, editorial boards (e.g., Microbial Risk Analysis ), and international conference chairs. His work bridges academia, industry, and policy to enhance food safety standards globally.

Finlay Maguireمشاهده پروفایل

استادیار

• Genomic Epidemiology
• Health Data Science
• Bioinformatics
• +۷ مورد دیگر

Finlay Maguire is an Assistant Professor jointly appointed in the Faculty of Computer Science and the Department of Community Health & Epidemiology at Dalhousie University. He leads the Maguire Lab, which develops data-driven methods to address health and social crises through genomic epidemiology and interdisciplinary health data science. He is also affiliated with the Shared Hospital Laboratory, Sunnybrook Research Institute, and multiple national and international public health consortia including PHA4GE, CanCOGeN, and IRIDA. PhD: University College London / Natural History Museum (2016) MA: University of Oxford (2011) Donald Hill Family Fellowship, Dalhousie University (2021) Dr. Maguire's research focuses on two main areas: genomic epidemiology of infectious diseases and interdisciplinary health data science collaborations . His work in genomic epidemiology includes developing bioinformatics and machine learning tools to study antimicrobial resistance (AMR) and SARS-CoV-2 dynamics, often in collaboration with public health agencies. His broader health data science work addresses issues such as online radicalization, healthcare access for refugees, and autism-related language use, combining computational methods with social science. His recent publications (2023–2025) reflect a strong trend in pathogen genomics , AMR , zoonotic spillover , and computational social science . He has published on novel coronaviruses in bats, SARS-CoV-2 animal models, invasive Group A Streptococcus, and sociological analyses of incel communities. Much of this work involves tool development (e.g., ArgNorm, Pathoplexus) and data standardization (e.g., PHA4GE metadata standards). Finalist, 2024 Discovery Awards (Emerging Professional) 2023 President’s Research Excellence Award for an Emerging Investigator, Dalhousie Finalist, 2023 Discovery Awards (Emerging Professional) Funding from CIHR, NSERC, Genome Canada, SSHRC, BMGF Dr. Maguire actively mentors graduate students and postdocs, including PhD candidates in Computer Science and MSc students in Community Health & Epidemiology. He has secured major training grants such as the CIHR Health Research Training Platform and the Canadian One Health Training Program for Emerging Zoonoses. He also contributes to capacity-building initiatives like MicroResearch in Ghana and Kenya. The Maguire Lab is embedded in a rich network of collaborations, including the CARD database, Public Health Agency of Canada, Canadian Food Inspection Agency, and Sunnybrook Health Sciences Centre. The lab emphasizes open science, reproducible research, and interdisciplinary training, as seen in the development of open-source tools and participation in international consortia.

Karoline Faustمشاهده پروفایل

دانشیار

• Microbial community dynamics
• Microbial systems biology
• Bioinformatics
• +۶ مورد دیگر

Karoline Faust is an Associate Professor at KU Leuven, affiliated with the Laboratory of Molecular Bacteriology (Rega Institute) and the Faculty of Medicine . She contributes to the iSi Health and Leuven One Health institutes, and serves on senior academic councils. Her research spans microbial systems biology, focusing on community dynamics and network analysis. Education: PhD in bioinformatics (2010, KU Leuven) Affiliations: KU Leuven, ISME Journal editorial board, Belgian Society for Microbiology Her research investigates microbial community dynamics , systems biology approaches to microbiomes, and bioinformatics tool development . She specializes in modeling human gut microbiota , synthetic microbial communities , and environmental microbiomes (e.g., microplastic impacts on Daphnia microbiomes). Her work integrates metabolic modeling , network analysis , and experimental systems to understand microbial interactions. Recent publications highlight her contributions to microbial network inference , 16S rRNA sequencing protocols , microfluidics , and ecological modeling of microbiomes. She develops tools like manta , miaSim , and CoNet to analyze community structures. Teaching: Karoline co-teaches courses in microbiology, bioinformatics, and network analysis at KU Leuven, and has contributed to international workshops on microbial network inference. Scientific Engagement: She serves as Senior Editor at ISME Journal and Secretary of the Belgian Society for Microbiology .